Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release (PR) in Patients With Early Stage Parkinson's Disease

NCT01485172 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01485172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01485172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release (PR) in Patients With Early Stage Parkinson's Disease
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2012
Completion date
April 30, 2014
Enrollment
186 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease